Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Frost-&-Sullivan"

6 News Found

Roche Diagnostics India wins Frost & Sullivan 2021 India leadership award
Equipment | March 14, 2022

Roche Diagnostics India wins Frost & Sullivan 2021 India leadership award

Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making


Cipla wins Frost & Sullivan and Teri Sustainability award for `Challenger in Mega Large Business Pharma Sector’
Sustainability | January 13, 2022

Cipla wins Frost & Sullivan and Teri Sustainability award for `Challenger in Mega Large Business Pharma Sector’

The companies were evaluated via a comprehensive, in-depth assessment process that included a sustainability framework of 300 points each for – Purpose, Partnership, Planet and People


Hospitals to accelerate digital investments: Frost & Sullivan
Digitisation | October 14, 2021

Hospitals to accelerate digital investments: Frost & Sullivan

The survey revealed that improving customer experience (CX) and operational efficiencies are top priorities, which healthcare organizations aim to attain by deploying digital health solutions


LyondellBasell awarded the 2023 Global Medical Plastics Company of the year
News | August 13, 2023

LyondellBasell awarded the 2023 Global Medical Plastics Company of the year

LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions


Parexel bags Global Customer Value Leadership Award
News | October 20, 2022

Parexel bags Global Customer Value Leadership Award

The award recognizes Parexel for delivering the best decentralized trial experience for customers through its capabilities, expertise, and patient recruitment and retention strategies


CDMOs shifting focus to meet future demand
News | April 07, 2022

CDMOs shifting focus to meet future demand

An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines